NewAmsterdam Pharma (NAMS) Asset Utilization Ratio (2024 - 2026)

NewAmsterdam Pharma (NAMS) has 3 years of Asset Utilization Ratio data on file, last reported at 0.03 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 46.36% year-over-year to 0.03; the trailing twelve-month figure through Mar 2026 stood at 0.03 (down 46.36% YoY), and the FY2025 full-year result was 0.03, down 63.37% from the prior year.
• Asset Utilization Ratio climbed to 0.03 in Q1 2026, from 0.03 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.08 in Q2 2025 to a low of 0.02 in Q2 2024.
• A 3-year average of 0.05 and a median of 0.04 in 2025 frame the typical range for Asset Utilization Ratio.
• Peak annual rise in Asset Utilization Ratio reached 393.56% in 2025, while the deepest fall reached 58.61% in 2025.
• Tracing NAMS's Asset Utilization Ratio over 3 years: stood at 0.07 in 2024, then plunged by 58.61% to 0.03 in 2025, then rose by 3.87% to 0.03 in 2026.
• Business Quant data shows NAMS's Asset Utilization Ratio at 0.03 in Q1 2026, 0.03 in Q4 2025, and 0.04 in Q3 2025.